Regenix Super Speciality Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 18-06-2024
- Paid Up Capital ₹ 1.19 Cr
as on 18-06-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.11 M
as on 18-06-2024
- Revenue 0.33%
(FY 2023)
- Profit -235.57%
(FY 2023)
- Ebitda -145.73%
(FY 2023)
- Net Worth -27.36%
(FY 2023)
- Total Assets -10.64%
(FY 2023)
About Regenix Super Speciality Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.19 Cr.
The company currently has active open charges totaling ₹1.11 M.
Samugounder Subramaniam, Malathi Ramamurthy, Ramamurthy Ayyavuthevar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300TN2011PTC080777
- Company No.
080777
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2011
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Regenix Super Speciality Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malathi Ramamurthy  | Managing Director | 15-Apr-2012 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samugounder Subramaniam | Whole-Time Director | 24-May-2011 | Current |
| Ramamurthy Ayyavuthevar | Director | 24-May-2011 | Current |
| Samini | Whole-Time Director | 01-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Regenix Super Speciality Laboratories.
Regenix Super Speciality Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.33% increase. The company also saw a substantial fall in profitability, with a 235.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regenix Super Speciality Laboratories?
In 2023, Regenix Super Speciality Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regenix Drugs LimitedActive 17 years 7 monthsMalathi Ramamurthy and Ramamurthy Ayyavuthevar are mutual person
Regenix Biosciences LimitedActive 18 years 9 monthsMalathi Ramamurthy and Ramamurthy Ayyavuthevar are mutual person
Prime Pharmaceuticals Private LimitedActive 29 years 3 monthsRamamurthy Ayyavuthevar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Nov 2023 | ₹1.11 M | Open |
How Many Employees Work at Regenix Super Speciality Laboratories?
Regenix Super Speciality Laboratories has a workforce of 70 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regenix Super Speciality Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Super Speciality Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
